top of page

AstraZeneca’s new antibiotic Zavicefta approved in the EU

The European Commission (EC) has granted marketing authorisation for AstraZeneca’s combination antibiotic Zavicefta (ceftazidime-avibactam) for the treatment of patients with serious Gram-negative bacterial infections requiring hospitalisation.


Click on this link for more information.

source: http://www.europeanpharmaceuticalreview.com/42007/news/industry-news/zavicefta-astrazeneca-eu/

#Pharmanews

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page